Real-time enrollment status for this ipf clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:47 AM UTC
| NCT Number | NCT05389215 |
| Recruiting Status | Recruiting |
| Condition | IPF |
| Phase | Clinical Trial |
| Target Enrollment | 102 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Daewoong Pharmaceutical Co. LTD. |
| Last Updated on CT.gov | August 5, 2025 (Aug 5, 2025) |
As of March 2, 2026: Clinical trial NCT05389215 is currently recruiting participants. This clinical trial study for ipf is actively seeking new participants at 20 locations across the United States. The study is sponsored by Daewoong Pharmaceutical Co. LTD.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05389215 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05389215 was last updated Aug 5, 2025 (August 5, 2025). HelloStudys verifies this status automatically.